01. Doctor Overview
Dr. Kemp Kernstine brings nearly three decades of experience to his patients at the University of Texas Southwestern’s Harold C. Simmons Comprehensive Cancer Center in Dallas, Texas. He currently heads the medical center’s Division of Thoracic Surgery, where he specializes in the surgical evaluation and treatment of mesothelioma, lung cancer, esophageal cancer and thymic cancers.
Dr. Kernstine’s work focuses on the surgical treatment of chest diseases, including mesothelioma and other asbestos-related diseases. He is especially interested in minimally invasive and robotic surgery procedures, a relatively new set of surgical techniques that reduces risk and recovery time for patients. Other areas of interest for Dr. Kernstine include the treatment of benign esophageal diseases such as esophageal masses, achalasia, hiatal hernia and gastroesophageal reflux disease.
Dr. Kernstine’s achievements with benign and malignant chest diseases have been recognized both in the United States and internationally. He has published numerous articles and books on chest surgery and lung and esophageal cancer, including Lung Cancer: A Multidisciplinary Approach to Diagnosis and Management, which he co-authored with Karen Reckamp.
02. Fast Facts
Doctor Fast Facts
Main Speciality: Thoracic Surgery
Other Interests & Specialties: Mesothelioma, adult general thoracic surgery, minimally invasive thoracic surgery, pediatric, thoracic surgery and thoracic surgical oncology.
Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, American Board of Surgery Certification in Thoracic and Cardiac Surgery, American Chemical Society Fellow, member of the American Medical Association, member of the American College of Surgeons, Castle Connolly Top Doctor, 2003 Thoracic Alumnus of the Year at Brigham & Women’s Hospital, Willem J. Kolff Young Investigator’s Award
Education & Experience:
- Residency for General Surgery at University of Minnesota at Fairview
- Fellowship for Thoracic Surgery at Brigham and Women’s Hospital
- Medical Degree from Duke University School of Medicine
A practical guide of the southwest oncology group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria. Journal of Thoracic Oncology. March 2011;6(3):598-601. doi: 10.1097/JTO.0b013e318208c83d
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation. Journal of Thoracic Oncology. December 2016;11(12):2082-2088. doi: 10.1016/j.jtho.2016.09.123
Identification of novel autoantibodies for detection of malignant mesothelioma. PLOS One. August 2013;8(8):e72458. doi: 10.1371/journal.pone.0072458
Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. Journal of Thoracic Oncology. August 2011;6(8):1304-12. doi: 10.1097/JTO.0b013e3182208e3f
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress. Clinical Lung Cancer. November 2009;10(6):395-404. doi: 10.3816/CLC.2009.n.075
Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer. Clinical Lung Cancer. November 2008;9(6):346-51. doi: 10.3816/CLC.2008.n.050